FDA approves generic version of Jazz Pharma's sleep disorder drug

Jan 17 (Reuters) - The U.S. Food and Drug Administration

said on Tuesday it had approved the first generic version of

Xyrem, Jazz Pharmaceuticals Plc's drug to treat

patients with a medical condition...

Read more